Fernández Javier, Bassegoda Octavi, Toapanta David, Bernal William
Liver ICU, Liver Unit, Hospital Clinic, University of Barcelona, IDIBAPS and CIBERehd, Spain.
EF Clif, EASL-CLIF Consortium, Barcelona, Spain.
JHEP Rep. 2024 Jun 10;6(9):101131. doi: 10.1016/j.jhepr.2024.101131. eCollection 2024 Sep.
Acute liver failure is a rare and dynamic condition, with a broad aetiology and an incompletely understood pathophysiology. Management of this life-threatening disease requires critical care and organ support and frequently early liver transplantation. Proper identification, prevention and treatment of complications such as intracranial hypertension and sepsis are critical to optimising outcomes. The identification of the cause of acute liver failure and the prompt initiation of the aetiological treatment can also improve prognosis. Survival has progressively improved in parallel to advances in medical treatment. Intracranial hypertension complicating hepatic encephalopathy is less frequent than in the past and intracranial pressure monitoring now relies on non-invasive techniques. Current prognostic models have good accuracy to identify patients who will die without liver transplantation but are not able to identify those in whom transplantation is futile. New prognostic markers to select patients for transplantation are still in the pipeline. Therapeutic plasma exchange and, in some centers, early renal replacement therapy are well established treatments for the disease. The use of other artificial liver devices in clinical practice is not supported by evidence. This review is intended to provide a clinical update on the management of acute liver failure, incorporating the most recent advances in the field.
急性肝衰竭是一种罕见且病情多变的病症,病因广泛,病理生理学尚不完全清楚。对这种危及生命的疾病进行管理需要重症监护和器官支持,且常常需要早期肝移植。正确识别、预防和治疗诸如颅内高压和脓毒症等并发症对于优化治疗结果至关重要。识别急性肝衰竭的病因并迅速启动病因治疗也可改善预后。随着医学治疗的进展,生存率已逐步提高。与肝性脑病并发的颅内高压比过去少见,目前颅内压监测依赖于非侵入性技术。当前的预后模型在识别那些不进行肝移植就会死亡的患者方面具有良好的准确性,但无法识别那些移植无用的患者。用于选择移植患者的新预后标志物仍在研发中。治疗性血浆置换以及在一些中心开展的早期肾脏替代治疗是该疾病已确立的治疗方法。临床实践中使用其他人工肝装置尚无证据支持。本综述旨在提供急性肝衰竭管理的临床最新进展,纳入该领域的最新研究成果。